What Is Beyaz?

Beyaz-yaz-yasmin-ocella-dangerous drugs / The Maher Law Firm / Frank Eidson Attorney At Law

Beyaz is an oral contraceptive manufactured by Bayer

Beyaz is made of several ingredients including ethinylestradiol, and estrogen and drospirenone a synthetic progestogen, which makes it a “combined oral contraceptive”.  Beyaz was approved by the FDA (Food and Drug Administration) on September 24th 2010.

One of the key ingredients in Beyaz called ‘Drospirenone’ is a synthetic, steroidal progestin that prevents ovulation, (the release of an egg from an ovary) which causes changes in your cervical and uterine lining.

Drospirenone has been linked with a possible increased risk of blood clots, making it more likely to cause blood clots than other types of birth control pills. Drospirenone can be found in many types of birth control pills (oral contraceptives) including Yaz, Yasmin and Ocella.  If you smoke, you increase your risk of blood clots, stroke, or heart attack caused by birth control pills.

Blood Clots, also known as DVT (Deep Vein thrombosis) can be a dangerous condition which may result in:

Heart Attack - When a blood clot travels to the heart it can cause a heart attack
Stroke – When a blood clot travels to the brain it can cause a stroke
Pulmonary Embolism – When a blood clot travels to the lungs it causes PE (Pulmonary Embolism)
Death – When any of the above occur the conditions may be fatal

Beyaz and any other birth control pill containing drospirenone are dangerous drugs that have serious side effects including, but not limited to:

Swelling of the face, lips, tongue, or throat
Hives
Difficulty breathing
Numbness of the body
Headaches – including migraine headaches
Chest pain
Nausea
Breast Lumps
Depression
Darkening of facial skin
Vaginal discharge
Decreased sex drive

If you believe that you or a loved one has suffered injury or death due to a defective or dangerous pharmaceutical, you may have a right to compensation for your injuries.  The Maher Law Firm and Frank Eidson Attorney At Law, would like to help.

 

What We Now Know About Yaz, Yasmin and Ocella

Once Upon A Time………Yaz, Yasmin and Ocella were thought to be “different” forms of birth control that would helped offer some relief for those suffering from  PMDD (Premenstrual Dysphoric Disorder)

We now know that Yaz, Yasmin and Ocella birth control pills have a 74% increased risk for blood clots or venous thromboembolism, due to the synthetic progestin hormone known as Drospirenone.  Blood clots can break loose from the vein, move through the body and into the lungs, causing a pulmonary embolism which can result in death.

Each Yaz, Yasmin and Ocella birth control pill contains 3mg of Drospirenone.

As of April 2012, the FDA (Food and Drug Administration) required new labeling for birth control pills containing drospirenone that include the following information:

    • A summary of the previously released results of the FDA funded study regarding the blood clot risk.
      -AND-
    • That some epidemiologic studies show as high as a threefold increased risk for blood clots for birth control pills containing drospirenone.

Drospirenone also suppresses the secretion of the hormones that regulate the body’s water and electrolytes, which may cause higher potassium levels.

If you believe that you or a loved one has suffered injury or death due to a defective or dangerous pharmaceutical, you may have the right to compensation for your injuries.  The Maher Law Firm and Frank M. Eidson would like to help.  We invite you to contact our trial tested Yaz, Yasmin & Ocella Lawyers today.

FDA Warns Oral Contraceptives – Yaz, Yasmin – Have High Risk Of Blood Clots

Oral contraceptives that contain drospirenone have a threefold increase for risk of blood clots

The FDA (Food and Drug Administration) “has concluded that drospirenone containing birth control pills may be associated with a higher risk for blood clots than other progestin containing pills.”

Nine oral contraceptives containing 3mg of drospirenone and either 0.02 or 0.03 mg of ethinyl estradiol, will now note the risk of blood clots on their labels.  The oral contraceptives include:  Yaz, Yasmin, Ocella, Zarah, Beyaz, Gianvi, Syeda, Loryna, Safyral.

If you believe that you or a loved one has suffered injury or death due to a defective or dangerous pharmaceutical, you may have the right to compensation for your injuries.  The Maher Law Firm and Frank M. Eidson would like to help.  We invite you to contact our trial tested Yaz, Yasmin & Ocella Lawyers today.

BMJ Study Confirms Yaz Significantly Increases Clotting Risks

On October 25, 2011, The British Medical Journal published a study confirming previous findings that newer-generation birth control pills, specifically those containing the progestogen hormones drospirenone, desogestrel or gestodene, double the risk for venous thromboembolism (VTE), compared to older-generation contraceptives containing the progestogen hormone, levonorgestrel. Widely-used and incredibly popular brands like as Yasmin, Yaz and Ocella are all examples of the types of birth control pills currently under intense scrutiny by the U.S. Food and Drug Administration, as well as other regulatory agencies and watchdog groups.

The study, which was led by Dr. Ojvind Lidegaard of the University of Copenhagen, included approximately 1.2 million non-pregnant women between the ages of 15 and 49 with no previous history of thrombotic disease. The results revealed that women taking older-generation birth control pills were three times more likely to develop VTE, compared to those not taking any hormonal contraceptive. Alarmingly, however, women taking drospirenone-containing birth control pills were at six to seven times the risk for VTE compared to non-users. The data undoubtedly confirms that women taking newer-generation birth control pills are at an increased risk for developing potentially serious and even life-threatening blood clots.

VTE is a blood clot that forms deep within a leg vein, and can be especially dangerous (even deadly) if the clot travels to the heart, brain or lungs. Women taking a drospirenone-containing birth control pills, should be aware of the warning signs of VTE, which include continuous and severe leg pain, severe chest pain or shortness of breath.

FDA Still Concerned About Drospirenone-Containing Birth Control Pills

The U.S. Food and Drug Administration today posted a drug safety communication on their website, announcing that preliminary results of an agency-funded study involving 800,000 women suggest a 1.5-fold increase in the risk of blood clots for those women using drospirenone-containing birth-control pills, compared to those taking other forms of hormonal contraceptives. The popular and controversial brands Yaz and Yasmin, both products of Bayer AG, are prime examples of the type of drospirenone-containing pills currently under scrutiny by federal regulators.

While the FDA has yet to reach a final conclusion that drospirenone-containing pills raise the risk for blood clots beyond that of other pills, the regulatory agency still remains greatly concerned over the potentially fatal side effects linked to use of birth control pills that contain drospirenone. At present, conflicting information from a number of published studies regarding the blood-clot risk associated with drospirenone, has prompted the FDA to convene an outside panel of medical experts in order to further discuss the issue.

According to drug manufacturer, Bayer, available scientific evidence shows that the risk for developing blood clots as a result of taking birth-control pills containing drospirenone is “comparable” to that of other pills studied, but the company is still working with the FDA on the matter.

FDA Announces Safety Review of Birth Control Pills

The U.S. Food and Drug Administration announced recently that it will conduct a safety review of birth control pills that contain the progestin hormone, drospirenone. The review was prompted by the findings of two published studies which assert that women taking birth control pills containing drospirenone may have an increased risk of developing blood clots.

Brand names of drospirenone-containing products include: Yaz (its generics, Gianvi and Loryna), Yasmin (its generics, Ocella, Syeda and Zarah), Beyaz and Safryral. While blood clots are a potential side effect of all birth control pills, the data from the two new reports caused the FDA to state, “This risk is reported to be up to two to three times greater than the risk of thromboembolism associated with using levonorgestrel-containing pills.”

The FDA’s safety review will involve more than 800,000 U.S. women and results are expected later this summer.